Staff of the
Research Institute of Epidemiology, Microbiology and Infectious Diseases is
developing new physiologically friendly drugs for correction of the microflora
and prevention of dysbiotic changes in the body.
The agents being
developed are based on bacteria of bacillus genus. The drugs can be widely used
in the treatment of a range of oral and intestinal diseases caused by an
imbalanced microflora.